Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
0.9900
-0.1170 (-10.57%)
May 26, 2026, 2:11 PM EST

Nuo Therapeutics Statistics

Total Valuation

AURX has a market cap or net worth of 47.92 million. The enterprise value is 47.73 million.

Market Cap47.92M
Enterprise Value 47.73M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date Aug 13, 2026
Ex-Dividend Date n/a

Share Statistics

AURX has 48.40 million shares outstanding. The number of shares has increased by 3.50% in one year.

Current Share Class 48.40M
Shares Outstanding 48.40M
Shares Change (YoY) +3.50%
Shares Change (QoQ) +0.46%
Owned by Insiders (%) 47.96%
Owned by Institutions (%) 2.13%
Float 20.29M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.60
PB Ratio -34.63
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -20.02
EV / Sales 11.55
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -28.13

Financial Position

The company has a current ratio of 1.11

Current Ratio 1.11
Quick Ratio 0.83
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.05
Interest Coverage -12.71

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -89.65%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -384.78%
Weighted Average Cost of Capital (WACC) -4,559.01%
Revenue Per Employee 413,124
Profits Per Employee -238,455
Employee Count10
Asset Turnover 2.67
Inventory Turnover 8.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -36.09% in the last 52 weeks. The beta is -831.10, so AURX's price volatility has been lower than the market average.

Beta (5Y) -831.10
52-Week Price Change -36.09%
50-Day Moving Average 1.34
200-Day Moving Average 1.74
Relative Strength Index (RSI) 38.91
Average Volume (20 Days) 5,407

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, AURX had revenue of 4.13 million and -2.38 million in losses. Loss per share was -0.05.

Revenue4.13M
Gross Profit 2.70M
Operating Income -2.22M
Pretax Income -2.38M
Net Income -2.38M
EBITDA -2.13M
EBIT -2.22M
Loss Per Share -0.05
Full Income Statement

Balance Sheet

The company has 263,827 in cash and 78,949 in debt, with a net cash position of 184,878 or 0.00 per share.

Cash & Cash Equivalents 263,827
Total Debt 78,949
Net Cash 184,878
Net Cash Per Share 0.00
Equity (Book Value) -1.38M
Book Value Per Share -0.03
Working Capital 151,003
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.65 million and capital expenditures -45,719, giving a free cash flow of -1.70 million.

Operating Cash Flow -1.65M
Capital Expenditures -45,719
Depreciation & Amortization 92,372
Net Borrowing 1.00M
Free Cash Flow -1.70M
FCF Per Share -0.04
Full Cash Flow Statement

Margins

Gross margin is 65.46%, with operating and profit margins of -53.69% and -57.72%.

Gross Margin 65.46%
Operating Margin -53.69%
Pretax Margin -57.72%
Profit Margin -57.72%
EBITDA Margin -51.45%
EBIT Margin -53.69%
FCF Margin n/a

Dividends & Yields

AURX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.50%
Shareholder Yield -3.50%
Earnings Yield -4.98%
FCF Yield -3.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3